Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Dominique GENRE"'
Autor:
Bernard Lelong, Cécile de Chaisemartin, Helene Meillat, Sandra Cournier, Jean Marie Boher, Dominique Genre, Mehdi Karoui, Jean Jacques Tuech, Jean Robert Delpero, the French Research Group of Rectal Cancer Surgery (GRECCAR)
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background Total mesorectal excision is the standard surgical treatment for mid- and low-rectal cancer. Laparoscopy represents a clear leap forward in the management of rectal cancer patients, offering significant improvements in post-operat
Externí odkaz:
https://doaj.org/article/256280ba00ba42a497b8e0dc44c63ac8
Autor:
Emmanuelle Charafe-Jauffret, Patrick Sfumato, Jean-Yves Pierga, Renaud Sabatier, Hervé Curé, Christophe Ginestier, Patrice Viens, Gilles Houvenaeghel, Dominique Genre, Jean-Marc Extra, Anthony Gonçalves, Eric Lambaudie, François Bertucci
Publikováno v:
Journal of Clinical Medicine Research
Journal of Clinical Medicine Research, Elmer Press, 2019, 8 (5), pp.612. ⟨10.3390/jcm8050612⟩
Journal of Clinical Medicine, Vol 8, Iss 5, p 612 (2019)
Journal of Clinical Medicine
Journal of Clinical Medicine Research, 2019, 8 (5), pp.612. ⟨10.3390/jcm8050612⟩
Journal of Clinical Medicine; Volume 8; Issue 5; Pages: 612
Journal of Clinical Medicine Research, Elmer Press, 2019, 8 (5), pp.612. ⟨10.3390/jcm8050612⟩
Journal of Clinical Medicine, Vol 8, Iss 5, p 612 (2019)
Journal of Clinical Medicine
Journal of Clinical Medicine Research, 2019, 8 (5), pp.612. ⟨10.3390/jcm8050612⟩
Journal of Clinical Medicine; Volume 8; Issue 5; Pages: 612
Preclinical works have suggested cytotoxic chemotherapies may increase the number of cancer stem cells (CSC) whereas angiogenesis inhibition may decrease CSC proliferation. We developed a proof of concept clinical trial to explore bevacizumab activit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a94922982b15e52cd69ee3b276a2ca54
https://hal.archives-ouvertes.fr/hal-02145624
https://hal.archives-ouvertes.fr/hal-02145624
Autor:
R. Lamy, Patrice Viens, J-L. Raoul, Rémy Largillier, Mohamed Gasmi, J.F. Seitz, Benjamin Esterni, J. R. Delpero, Hervé Perrier, Olivier Turrini, Laurence Moureau-Zabotto, X. Tchiknavorian, M Giovannini, E. Francois, Dominique Genre, A. Goncalves, D. Re, Marine Gilabert, Laetitia Dahan
Publikováno v:
Annals of Oncology. 23:2799-2805
Background Sorafenib is an oral anticancer agent targeting Ras-dependent signaling and angiogenic pathways. A phase I trial demonstrated that the combination of gemcitabine and sorafenib was well tolerated and had activity in advanced pancreatic canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f759a652be19ef663edd6fe132a07cc
https://doi.org/10.1093/annonc/mds135
https://doi.org/10.1093/annonc/mds135
Autor:
Julien Mancini, Dominique Genre, Aline Sarradon-Eck, Claire Julian-Reynier, Juliette Sakoyan, Alice Desclaux
Publikováno v:
Social science & medicine
Social science & medicine, Elsevier, 2012, 75 (5), pp.873-882. ⟨10.1016/j.socscimed.2012.04.022⟩
Social science & medicine, Elsevier, 2012, 75 (5), pp.873-882. ⟨10.1016/j.socscimed.2012.04.022⟩
Disclosing overall scientific results to clinical trial participants has become an ethical obligation. Here we studied how participants understand these results in view of their experience of clinical trials and illness in general and what modes of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::999522fd54434e259a3abd88ea32e628
https://doi.org/10.1016/j.socscimed.2012.04.022
https://doi.org/10.1016/j.socscimed.2012.04.022
Autor:
Jean-Marc Ferrero, Patrice Viens, Pierre Kerbrat, Anne-Laure Martin, Claire Julian-Reynier, Florence Dalenc, Julien Mancini, Françoise Maylevin, Dominique Genre, Carole Tarpin, Henri Roché, Corinne Gamet
Publikováno v:
Journal of Clinical Epidemiology. 65:635-642
Objective To identify the factors associated with long-term regrets expressed a posteriori by randomized controlled trial (RCT) participants questioned about their decision to participate in an RCT. Study Design and Setting Participants were question
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0952fb09ab87e7a9b4b955f6cd713919
https://doi.org/10.1016/j.jclinepi.2011.12.003
https://doi.org/10.1016/j.jclinepi.2011.12.003
Autor:
Julien Mancini, Rémy Largillier, A. Monnier, Daniel Serin, Jean Genève, Henri Roché, M. Rios, Pierre Kerbrat, Claire Julian-Reynier, C. Tarpin, Florence Dalenc, Dominique Genre, M. Jimenez
Publikováno v:
Oncologie. 10:149-154
L’objectif de cette etude etait de comparer les attitudes theoriques par rapport a la participation ou non a un essai randomise controle (ERC) de trois groupes comparables de patientes suivies prospectivement (cancer du sein non metastatique traite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09f32ba0bc7e44317dcf28cf6d156c5c
https://doi.org/10.1007/s10269-007-0827-6
https://doi.org/10.1007/s10269-007-0827-6
Autor:
Marta Jimenez, Claire Julian Reynier, Pierre Kerbrat, Rémy Largillier, Julien Mancini, Carole Tarpin, Dominique Genre, Maria Rios, Daniel Serin, A. Monnier, Jean Genève, Henri Roché, Florence Dalenc
Publikováno v:
Contemporary Clinical Trials. 28:684-694
The aim of this study was to measure women's preferences about decision-making and their impact to participate or not to a hypothetical randomised controlled trial (RCT).We surveyed prospectively breast cancer patients invited to participate in a cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0e75d74f442ece7a08f8add69fd2a3a
https://doi.org/10.1016/j.cct.2007.03.001
https://doi.org/10.1016/j.cct.2007.03.001
Autor:
A. Monnier, Marta Jimenez, Dominique Maraninchi, Rémy Largillier, Florence Dalenc, Daniel Serin, Carole Tarpin, Jean Genève, Henri Roché, Pierre Kerbrat, Dominique Genre, Maria Rios, Claire Julian-Reynier
Publikováno v:
Journal of Clinical Oncology. 25:3038-3044
Purpose Cancer patients participating in randomized controlled trials (RCTs) have not been found to have better clinical outcomes than other patients. Our objective was to assess the impact of RCTs on patients' satisfaction with care. Patients and Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b23de91e797d0a5d3698a8b1f74b6c5b
https://doi.org/10.1200/jco.2006.08.9367
https://doi.org/10.1200/jco.2006.08.9367
Autor:
Valérie-Jeanne Bardou, Dominique Maraninchi, G Gravis, J. Jacquemier, Dominique Genre, Christian Chabannon, Danielle Sainty, Patrice Viens, C Arnoulet, Patrick Ladaique, François Bertucci, Anthony Gonçalves, G Houvenaeghel, F Viret, A C Braud
Publikováno v:
Bone Marrow Transplantation. 32:1059-1064
The purpose of this study was to evaluate the presence of micrometastatic cells in the apheresis products from patients with breast cancer, and also to determine if repeated infusion of contaminated products had any clinical impact. A total of 94 pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58c810eab5b9573fd4306d18577d7c6e
https://doi.org/10.1038/sj.bmt.1704283
https://doi.org/10.1038/sj.bmt.1704283
Autor:
Jacques Camerlo, Dominique Maraninchi, Dominique Genre, Gérard Serment, Patrice Viens, Naji Salem, Franck Bladou, Gwenaelle Gravis, Geneviève Macquart-Moulin, Valerie-Jeanne Bardou
Publikováno v:
Cancer. 98:1627-1634
BACKGROUND The current Phase II study investigated the clinical benefit, impact on quality of life (QOL), and tolerability of weekly docetaxel in symptomatic patients with metastatic hormone-refractory prostate carcinoma (HRPC). METHODS Patients rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9da5a9e68db42a6fe3b37a7a49f33887
https://doi.org/10.1002/cncr.11687
https://doi.org/10.1002/cncr.11687